GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Suzhou Basecare Medical Corp Ltd (HKSE:02170) » Definitions » Piotroski F-Score

Suzhou Basecare Medical (HKSE:02170) Piotroski F-Score : 3 (As of Jun. 21, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Suzhou Basecare Medical Piotroski F-Score?

Warning Sign:

Piotroski F-Score of 3 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Suzhou Basecare Medical has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Suzhou Basecare Medical's Piotroski F-Score or its related term are showing as below:

HKSE:02170' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 4   Max: 5
Current: 3

During the past 6 years, the highest Piotroski F-Score of Suzhou Basecare Medical was 5. The lowest was 1. And the median was 4.


Suzhou Basecare Medical Piotroski F-Score Historical Data

The historical data trend for Suzhou Basecare Medical's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzhou Basecare Medical Piotroski F-Score Chart

Suzhou Basecare Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial N/A 5.00 4.00 1.00 3.00

Suzhou Basecare Medical Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 3.00 1.00 - 3.00

Competitive Comparison of Suzhou Basecare Medical's Piotroski F-Score

For the Medical Devices subindustry, Suzhou Basecare Medical's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suzhou Basecare Medical's Piotroski F-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Suzhou Basecare Medical's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Suzhou Basecare Medical's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was HK$-209.7 Mil.
Cash Flow from Operations was HK$-292.3 Mil.
Revenue was HK$227.5 Mil.
Gross Profit was HK$99.9 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was (1987.594 + 2076.087) / 2 = HK$2031.8405 Mil.
Total Assets at the begining of this year (Dec22) was HK$1,987.6 Mil.
Long-Term Debt & Capital Lease Obligation was HK$291.7 Mil.
Total Current Assets was HK$1,329.1 Mil.
Total Current Liabilities was HK$213.6 Mil.
Net Income was HK$-137.0 Mil.

Revenue was HK$157.3 Mil.
Gross Profit was HK$66.5 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was (2205.129 + 1987.594) / 2 = HK$2096.3615 Mil.
Total Assets at the begining of last year (Dec21) was HK$2,205.1 Mil.
Long-Term Debt & Capital Lease Obligation was HK$82.0 Mil.
Total Current Assets was HK$1,705.9 Mil.
Total Current Liabilities was HK$127.9 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Suzhou Basecare Medical's current Net Income (TTM) was -209.7. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Suzhou Basecare Medical's current Cash Flow from Operations (TTM) was -292.3. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=-209.661/1987.594
=-0.10548482

ROA (Last Year)=Net Income/Total Assets (Dec21)
=-136.981/2205.129
=-0.06211927

Suzhou Basecare Medical's return on assets of this year was -0.10548482. Suzhou Basecare Medical's return on assets of last year was -0.06211927. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Suzhou Basecare Medical's current Net Income (TTM) was -209.7. Suzhou Basecare Medical's current Cash Flow from Operations (TTM) was -292.3. ==> -292.3 <= -209.7 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=291.745/2031.8405
=0.14358657

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=81.96/2096.3615
=0.03909631

Suzhou Basecare Medical's gearing of this year was 0.14358657. Suzhou Basecare Medical's gearing of last year was 0.03909631. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=1329.123/213.577
=6.22315605

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=1705.889/127.922
=13.33538406

Suzhou Basecare Medical's current ratio of this year was 6.22315605. Suzhou Basecare Medical's current ratio of last year was 13.33538406. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Suzhou Basecare Medical's number of shares in issue this year was 273.526. Suzhou Basecare Medical's number of shares in issue last year was 273.526. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=99.918/227.48
=0.43923861

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=66.476/157.346
=0.42248294

Suzhou Basecare Medical's gross margin of this year was 0.43923861. Suzhou Basecare Medical's gross margin of last year was 0.42248294. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=227.48/1987.594
=0.11444993

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=157.346/2205.129
=0.07135456

Suzhou Basecare Medical's asset turnover of this year was 0.11444993. Suzhou Basecare Medical's asset turnover of last year was 0.07135456. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+0+0+0+1+1+1
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Suzhou Basecare Medical has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

Suzhou Basecare Medical  (HKSE:02170) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Suzhou Basecare Medical Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Suzhou Basecare Medical's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Suzhou Basecare Medical (HKSE:02170) Business Description

Traded in Other Exchanges
N/A
Address
BioBay, No. 218 Xinghu Street, Unit 101, Building A3, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215000
Suzhou Basecare Medical Corp Ltd is engaged in providing genetic testing solutions for assisted human reproduction. The company generates revenues from Sales of testing kits, followed by Sales of testing devices and instruments. Basecare focuses on the assisted reproductive sector, such as pre-implantation genetic screening and diagnosis, non-invasive prenatal DNA testing, and chromosome abnormalities testing. It generates revenue from China.
Executives
Orbimed Capital Llc 2102 Investment manager
Lake Bleu Prime Healthcare Master Fund Limited 2201 Interest of corporation controlled by you
Orbimed Partners Master Fund Limited 2101 Beneficial owner
Dawn Capital Fund 2101 Beneficial owner
Dawn Capital Limited 2102 Investment manager
Hh Spr-xiv Cy Holdings Limited 2201 Interest of corporation controlled by you
Hh Spr-xiv Hk Holdings Limited 2101 Beneficial owner
Hh Spr-xiv Holdings L.p. 2201 Interest of corporation controlled by you
Hillhouse Fund Iv, L.p. 2201 Interest of corporation controlled by you
Hillhouse Investment Management, Ltd. 2102 Investment manager

Suzhou Basecare Medical (HKSE:02170) Headlines

No Headlines